According to Spyre Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.18 B. In 2023 the company made an earning of -$0.13 B a decrease over its 2022 earnings that were of -$84.79 M.The earnings displayed on this page is the company's Pretax Income.